Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Reel/Frame: | 060806/0453 | |
| Pages: | 4 |
| | Recorded: | 07/21/2022 | | |
Attorney Dkt #: | ANDEXANET |
Conveyance: | CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). |
|
Total properties:
6
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17176939
|
Filing Dt:
|
02/16/2021
|
Publication #:
|
|
Pub Dt:
|
12/09/2021
| | | | |
Title:
|
INHIBITION OF TISSUE FACTOR PATHWAY INHIBITOR WITH FACTOR XA DERIVATIVES
|
|
|
Patent #:
|
|
Issue Dt:
|
12/19/2023
|
Application #:
|
17196172
|
Filing Dt:
|
03/09/2021
|
Publication #:
|
|
Pub Dt:
|
11/11/2021
| | | | |
Title:
|
PREPARATION OF FACTOR XA DERIVATIVES
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17196197
|
Filing Dt:
|
03/09/2021
|
Publication #:
|
|
Pub Dt:
|
11/04/2021
| | | | |
Title:
|
ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING THE SAME
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17334427
|
Filing Dt:
|
05/28/2021
|
Publication #:
|
|
Pub Dt:
|
09/16/2021
| | | | |
Title:
|
LYOPHILIZED FORMULATIONS FOR FACTOR XA ANTIDOTE
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17569402
|
Filing Dt:
|
01/05/2022
|
Publication #:
|
|
Pub Dt:
|
01/05/2023
| | | | |
Title:
|
UNIT DOSE FORMULATION OF ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING THE SAME
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
06/11/2024
|
Application #:
|
17698718
|
Filing Dt:
|
03/18/2022
|
Publication #:
|
|
Pub Dt:
|
11/10/2022
| | | | |
Title:
|
LYOPHILIZED FORMULATIONS FOR FACTOR XA ANTIDOTE
|
|
Assignee
|
|
|
270 E. GRAND AVE. |
SOUTH SAN FRANCISCO, CALIFORNIA 94080 |
|
Correspondence name and address
|
|
ALEXION PHARMACEUTICALS, INC.
|
|
100 COLLEGE STREET
|
|
NEW HAVEN, CT 06510
|
Search Results as of:
05/22/2024 06:12 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|